Cepheid Stock

Stocks

01/05/12

15/02/17	Cepheid : Announces FDA Clearance Of Xpert® Xpress Flu And Xpert Xpress Flu/RSV	PU
05/11/16	Cepheid : Danaher Completes Acquisition Of Cepheid	PR
27/10/16	Cepheid : 30 Minute Or Less Molecular Flu/RSV Test Now Available Outside The US	PR
24/10/16	Cepheid : Announces Receipt of Required Regulatory Clearances in Proposed Acquisition by Danaher Corporation	PR
06/10/16	Cepheid : New Bladder Cancer Test Could Reduce Number Of Invasive Procedures Required For Recurrence Monitoring	PR

06/09/16	Danaher : renforce dans les diagnostics avec Cepheid
06/09/16	Danaher : acquiert le spécialiste des diagnostics Cepheid

Manager	Title	Age	Since
Charles Mwangi DFI	Director of Finance/CFO	59	01/07/2023
Anupama Mokkapati COO	Chief Operating Officer	-	01/11/2021
Laurent Bellon COO	Chief Operating Officer	-	01/08/2018

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
CEPHEID	-.--%	+0.36%	-	-	0
THERMO FISHER SCIENTIFIC, INC.	-3.56%	-3.59%	+20.45%	+50.26%	262B
DANAHER CORPORATION	-3.34%	-3.98%	+7.22%	+16.38%	165B
INTUITIVE SURGICAL, INC.	-3.97%	+2.97%	-15.77%	+66.66%	167B
BOSTON SCIENTIFIC CORPORATION	-3.61%	+3.32%	-55.40%	-16.48%	66.41B
EDWARDS LIFESCIENCES CORPORATION	-0.10%	+5.14%	+19.86%	+47.97%	57.28B
SIEMENS HEALTHINEERS AG	+0.33%	+4.92%	0.00%	-5.40%	56.02B
AGILENT TECHNOLOGIES, INC.	-2.96%	-4.60%	+17.74%	+60.71%	49.95B
VEEVA SYSTEMS INC.	-0.30%	-0.30%	+4.79%	+57.74%	50.29B
WATERS CORPORATION	-3.04%	-5.25%	+22.29%	+80.39%	45.94B
Average	-2.10%	+2.17%	+2.35%	+39.80%	102.22B
Weighted average by Cap.	-2.91%	+2.34%	+3.82%	+41.28%